Idiopathic Scoliosis
1
Pipeline Programs
2
Companies
2
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2024
2025
2026
2027
2028
2029
2030
2031
Human BioSciencesMethadone based ERAS
Globus MedicalREFLECT Scoliosis Correction System
Clinical Trials (2)
Total enrollment: 600 patients across 2 trials
Evaluation of Analgesia for Spine Fusion Elective Surgery in Children
Start: Oct 2025Est. completion: Aug 2029500 patients
Phase 3Recruiting
REFLECT Scoliosis System Post Approval Study
Start: Apr 2024Est. completion: Mar 2032100 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs, potential near-term approvals
2 actively recruiting trials targeting 600 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.